Botulinum toxin: Current trends in clinical therapeutics in ophthalmology;Utilisation de la toxine botulique en ophtalmologie: Concepts et problemes actuels

Journal Francais d'Ophtalmologie

Volumn 20, Issue 2, 1997, Pages 134-145

  Tapiero, B ^a   Robert, P Y ^b   Adenis, J P ^b   Riss, I ^a  

^a HÔPITAL PELLEGRIN   (France)

^b DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; BLEPHAROSPASM; CHILD; HEMIFACIAL SPASM; HUMAN; REVIEW; STRABISMUS;

ANTI-DYSKINESIA AGENTS; BLEPHAROSPASM; BOTULINUM TOXINS; FACIAL MUSCLES; HUMANS; OCULOMOTOR MUSCLES; SPASM;

EID: 0031049572     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. SHANTZ E.J., JOHNSON E.A. - Dose standardization of botulinum toxin. Lancet, 1990; :335-421.
2. ADENIS J.P., SMOLIK I., MAES S. - Traitement des spasmes faciaux par la toxine botulique A. J Fr Ophtalmol, 1990; 13:259-264.
3. DUTTON J.J., BUCKLEY E.G. - Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmogy, 1988; 95:1529-1534.
4. SIATKOWSKI R.M., TYUTYUNIKOV A., BIGLAN A.W., SCALISE D., GENOVESE C., KEENNERDELL J.S., FEUER W.J. - Serum Antibody Production to Botulinum A. Toxin Ophthalmology, 1993; 100:1861-1866.
5. BORODIC G.E., FERRANTE R. - Effects of repeated botulinum toxin injections on orbicularis oculi muscle. J Clin Neuro Ophthalmol, 1992; 12:121-127.
6. SCOTT A.B. - Le blépharospasme essentiel : publications récentes. Bulletin de l'Association des malades atteints de blépharospasme, 1995; 16:3.
7. VIAL C. - Remote effects of BTX injections. Movements disorders, 1995; 10:367.
8. BERARDELLI A., PRIORI A., MERCURI B. - Central effects of botulinum toxin. Evidences to support or to refuse. Movements Disorders, 1995; 10:364.
9. SANDERS D.B., MASSEY E.W., BUCKLEY E.G. - Botulinum toxin for blepharospasm : single-fiber EMG studies. Neurology, 1986; 36:545-547.
10. HALLEN M. - Clinical mode of action : critical review of potential mechanisms. Movements Disorders, 1995; 10:363.
11. HEEMS-BRAVI F. - Chirurgie du blépharospasme essentiel. Thèse Med., Limoges, 1994.
12. GEORGE J.L., MALET Th. - La chirurgie des blépharospasmes. Visions Internationales, 1994; 45:39-43.
13. FRUEH B.R., NELSON C.C., KAPUSTIAK J.F., MUSCH D.C. - The effect of omitting Botulinum Toxin from the lower eyelid in blepharospasm treatment. Am J Ophthalmol, 1988; 106:45-47.
14. MIRABEL S. - Le blépharospasme essentiel : publications récentes. Bulletin de l'Association des malades atteints de blépharospasme, 1995; 16:7-8.
15. ARAMIDEH M., SPEELMAN J.D., BRANS J.W.N., KOELMAN J.H.T.M., BOUR L.J., ONGERBOER DE VISSER B.W. - Application of botulinum into pretarsal portion of orbicularis oculi in the treatment of blepharospasm. Movements Disorders, 1995; 10:383.
16. KATZ B., ROSENBERG J.H. - Botulinum therapy for apraxia of eyelid opening. Am J Ophthalmol, 1987; 103:718-719.
17. OSAKO M., KELTNER J.L. - Botulinum A toxin (Oculinum) in ophthalmology. Surv Ophthalmol, 1991; 36:28-46.
18. OTIS P. - Comparison of Botulinum treatment of strabismus to standard strabismus surgery on a resident teaching service. Proceedings of the First International Symposium of Ophthalmology, Bordeaux, 1993, 401.
19. SCOTT A.B., KRAFT S.P. - Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology, 1985; 92:676-683.
20. SCOTT A.B., MAGOON E.H., McNEER K.W., STAGER D.R. - Botulinum treatment of childhood strabismus. Ophthalmology, 1990; 97:1434-1438.
21. SCOTT A.B. - Antitoxin reduces Botulinum side effects. Eye, 1988; 2:29-32.